See also:
All coronary artery disease clinical trials
All stable angina clinical trials
All clinical trials of anti-anginal drugs
All clinical trials of ranolazine 1000mg + amlodipine
|
|
Treatments
| Studied treatment |
ranolazine 1000 mg twice a day for 6 weeks + amlodipine (10 mg/d)
|
| Control treatment |
placebo + amlodipine (10 mg/d)
|
Patients
| Patients |
patients with stable chronic angina already treated with the maximal dose of amlodipine (10mg/d) |
Method and design
| Randomized effectives |
281 / 284 (studied vs. control) |
| Design |
Parallel groups |
| Blinding |
double blind |
| Follow-up duration |
6 weeks |
| Number of centre |
48 |
| Geographic area |
Europe, USA, Canada |
| Primary endpoint |
angina frequency |
Results
No results available for this trial
- no clinical endpoint reported
Reference(s)
-
Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L.
Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial..
J Am Coll Cardiol 2006 Aug 1;48:566-75
Pubmed
|
Hubmed
| Fulltext
|